DOI QR코드

DOI QR Code

Clinical Study for the Efficacy of External Preparation Containing Sophorae Radix, Aurantii Immaturus Fructus, Schizonepetae Spica, Forsythia fructus and Portulacea Herba Extract on Atopic Dermatitis

고삼(苦蔘), 지실(枳實), 형개(荊芥), 연교(連翹), 마치현(馬齒莧) 추출물이 포함된 외용제의 아토피 피부염에 대한 유효성 평가를 위한 임상연구

  • Received : 2014.01.14
  • Accepted : 2014.02.12
  • Published : 2014.02.25

Abstract

Objectives : The purpose of this study is to investigate the efficacy of external preparation containing herbal extract(Sophorae Radix, Aurantii Immaturus Fructus, Schizonepetae Spica, Forsythia fructus and Portulacea Herba) on atopic dermatitis patients. Methods : A total of 33 patients who visited the Dept. of Ophthalmology, Otolaryngology & Dermatology of Korean Medicine of Korean Medical hospital of Daejeon university from February 2012 to February 2013 were engaged in this study. Patients who corresponded the requirements were enrolled in the study. This study shows symptom comparisons before and after the use of this product. Effectiveness was evaluated through SCORAD(SCORing Atopic Dermatitis) Index, and the quality of life scale was conducted through Skindex-29. Results : 1. Comparison of the general changes through SCORAD Index indicated that the experimental group showed more statistically significant declines than the placebo group after the two-week use. 2. Comparison of changes in intensity criteria(Erythema, Edema, Oozing, Excoriation) through SCORAD Index indicated that the experimental group showed more statistically significant declines than the placebo group after the two-week use. 3. Comparison of changes in subjective symptoms through SCORAD Index indicated that the experimental group showed no statistically remarkable changes. 4. Comparison of changes in the body parts(Upperlimb) through SCORAD Index indicated the experimental group showed statistically significant changes after the two-week use. 5. Comparison of the general changes in quality of life through Skindex-29 indicated that the total score from experimental group showed statistically significant changes after the four-week use. Conclusions: This study, evaluated through SCORAD Index, indicated that the treatment with the external preparation containing herbal extract has a statistically marginal significance of efficacy on atopic dermatitis patients in the short term.

Keywords

Atopic dermatitis;External application;SCORAD index;Sophorae Radix;Aurantii Immaturus Fructus;Schizonepetae Spica;Forsythia fructus;Portulacea Herba

References

  1. Rho SS. Full-color Dermatology. Seoul:IBC Design. 2006:499, 512-27.
  2. Fitzpatrick Thomas B, Johnson Richard Allen, Wolff Klaus, Polano Machiel K, Suurmond Dick. Color atlas and synopsis of Clinical Dermatology. Seoul:Jungdam. 1999:54-63.
  3. Hanifin JM, Rajka RG. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92(suppl. 144):44-7.
  4. Park YL, Kim HD, Kim KH, Kim MN, Kim JW, Ro YS, et al. Report from ADRG;A Study on the Diagnostic Criteria of Korean Atopic Dermatitis. Korean Journal of Dermatology. 2006;44(6):659-63.
  5. College of Korean medicine Ponch'ohak Committee. Ponch'ohak. Seoul:Youngrim. 2004:159-160, 227, 244-5, 254, 395-6.
  6. Hong WK, Shin JH, Lee YH, Park DK, Choi GS. The Clinical Effect of Phellinus linteus Grown on Germinated Brown Rice in the Treatment of Atopic Dermatitis. Kor J Herbology. 2008;23(1):103-8.
  7. Yoon HS, Lee GY, Kim YB. Eight Cases of Atopic Dermatitis Treated with No-Hoe(Aloe vera L.) Extract Dressing. The Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology. 2004;17(3):153-66.
  8. Kim CH, Kim JT, Jung HA, Roh SS. Clinical Efficacy of External Preparation Containing Herbal Extracts in Atopic Dermatitis Patients. The Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology. 2007;20(2):187-98.
  9. Hwang SY, Hwangbo M, Jee SY, Kim SY, Kwon YG, Seo JC. A Clinical study of Atopic Dermatitis treated by external application with Gynostemma Pentaphyllum MAKINO in cosmetics. The Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology. 2007;20(3):212-21.
  10. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186(1):23-31. https://doi.org/10.1159/000247298
  11. Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol. 2003 Jun;120(6):932-41. https://doi.org/10.1046/j.1523-1747.2003.12251.x
  12. An BG, Lee SJ, Nam GG, Jeong YL, Lee SH. The Korean Version of Skindex-29. Korean Journal of Dermatology. 2004;42(1):9-15.
  13. Leung DYM. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J. Allergy Clin. Immunol. 2000;105:860-76. https://doi.org/10.1067/mai.2000.106484
  14. Park MC, Kim JM, Hong CH, Hwang CY. A literature study about the comparison of oriental occidental medicine on the atopic dermatitis. Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology. 2002;15(1):226-52.
  15. Ministry of Food and Drug Safety. The clinical trial guidelines of herbal medicine drug : Atopic dermatitis. Seoul:Biopharmaceuticals and Herbal Medicine Bureau. 2009.
  16. Yun HJ, Ko WS. Clinical Study of Atopic Dermatitis; the Classification of Oriental Medical Clinical type and Treatment. J Korean Oriental Med. 2001;22(2):10-21.
  17. Schultz Larsen F, Hanifin JM. Secular change in the occurrence of atopic dermatitis. Acta Derm Venereol Suppl. 1992;176:7-12.
  18. Ogawa H, Yoshiike T. A speculative view of atopic dermatitis: barrier dysfunction in pathogenesis. J Dermatol Sci. 1993;5:197-204. https://doi.org/10.1016/0923-1811(93)90767-J
  19. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis : an etiologic factor in atopic dry skin? J Invest Dermatol. 1991 Apr;96(4):523-6. https://doi.org/10.1111/1523-1747.ep12470233
  20. Horikawa T, Takashima T, Harada S, Chihara T, Ichihashi M. An open clinical trial of glycoceramide-containing cream and lotion on dry skin of atopic dermatitis. Hifu. 1998;40(4):415-9.
  21. Ahn DK. Illustrate Book Of Korean Medicinal Herbs. Seoul:Kyohak Publishing. 1998:34, 57.
  22. Jeong SI, Choi BM, Yun YG, Lee JW, Jang SI. A Noble Therapeutic Approach of Atopic dermatitis by Development of Th2 Chemokine Inhibitors from Natural Products : Inhibitory Effect of Sophora flavescens Extract in Atopic Dermatitis Model mice, NC/Nga. The Korean Journal of Oriental Medical Prescription. 2009;17(1):141-51.
  23. Song DH, Kim HJ. The Effect of Kushen Ethanol Extract Cream to NC/Nga mice Induced by Dermatophagoides farinae. Journal of Korean Beauty Society. 2009;15(4):1243-52.
  24. Kang SJ, Kim AJ, Lee YH, Lee MS, Joung KH, Cho NJ. The Enhancing Effect of Atopic Dermatitis by cosmetics containing estern medical herbs. Journal of the Korea Academia-Industrial cooperation Society. 2009;10(11):3500-5. https://doi.org/10.5762/KAIS.2009.10.11.3500
  25. Bor-Sen Wang, Guan-Jhong Huang, Huo-Mu Tai, Ming-Hsing Huang. Antioxidant and anti-inflammatory activities of aqueous extracts of Schizonepeta tenuifolia Briq. Food and Chemical Toxicology. 2012;50:526-31. https://doi.org/10.1016/j.fct.2011.12.010
  26. Yoo JS, Kim DK, Kim SH, Shin TY. Anti-allergic Effects of Schizonepeta tenuifolia on Mast Cell-Mediated Allergy Model. Natural Product Sciences. 2011;17(3):239-44.
  27. Cho SI. Regulatory mechanism of Schizonepeta tenuifolia Briquet on HMC-1 mast cells : microarray analysis. Graduate School of Kyung Hee University. 2009.
  28. Lim DH, Jeon YK, Kim WC. A Study on the Applications of Herba Schizonepetae Mainly Blended Prescription in Dongeuibogam. Korean Journal of Oriental Medical Prescription. 2009;17(2):21-38.
  29. Kim SH, Kim EJ, Kim JE, Nam HS, Kim YJ, Chung HM, et al. The Moisturizing and Cooling Effects of the Cosmetic Products Containing Scrophulariae Radix, Poria, Lonicerae Flos, Portulacea Herba and Ginko Folium Extract on Human Skin. Korean journal of herbology. 2007;22(2):45-50.
  30. Schmitt J, Langan S, Williams HC. European Dermato-Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol. 2007;120(6):1389-98. https://doi.org/10.1016/j.jaci.2007.08.011
  31. Finlay AY. Quality of life in atopic dermatitis. J Am Acad Dermatol. 2001;45:S64-6. https://doi.org/10.1067/mjd.2001.117010
  32. Lewis-Jones S. Quality of life and childhood atopic dermatitis : the misery of living with childhood eczema. Int J Clin Pract. 2006;60:984-92. https://doi.org/10.1111/j.1742-1241.2006.01047.x
  33. Kim MH, Kim JH, Yun HJ, Ko WS. Quality of Life in Patients with Skin Disease. J Korean Oriental Med. 2005;26(3):43-54.
  34. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Skindex, a quality-of-life instrument for patients with skin disease. Arch Dermatol. 1997;133:1433-40. https://doi.org/10.1001/archderm.1997.03890470111018

Cited by

  1. A Clinical Study for the Effect of External Applications Containing Herbal Extracts on Mild Atopic Dermatitis Patients vol.27, pp.3, 2014, https://doi.org/10.6114/jkood.2014.27.3.040